ArticleTransfusion2026
Identification and structural analysis of a novel FUT1 c.789C>A variant and previously reported para-Bombay alleles using an α2FucT1 structural model.
Article in Transfusion, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFUT1 encodes galactoside alpha-(1,2)-fucosyltransferase 1 (α2FucT1), which adds the H antigen glycan on red blood cells. In contrast, FUT2 encodes galactoside alpha-(1,2)-fucosyltransferase 2 (α2FucT2), which is primarily responsible for adding H antigen in secretions. When FUT1 loss-of-function variants occur in the presence of functional FUT2, RBCs can exhibit on their surface weak H antigen captured from secretions. This is known as the para-Bombay phenotype. STUDY DESIGN AND
methodsWhole genome sequencing (WGS) was conducted on a sample from a Hispanic individual exhibiting the para-Bombay phenotype. The analysis focused on FUT1, FUT2, and ABO. To assess potential loss-of-function missense variants in FUT1, a three-dimensional structural model of human α2FucT1 complexed with its donor substrate GDP-L-Fucose and its acceptor glycan Galβ1-4GlcNAc was generated using AlphaFold2 and refined through molecular docking.
resultsWhole genome sequencing revealed that the para-Bombay individual was homozygous for a rare FUT1 missense variant (c.789C>A, p.Asn263Lys). Structural modeling demonstrated that this substitution lies near the GDP-L-Fucose binding site in the donor glycan pocket, leading to a predicted alteration in electrostatic charge distribution. Moreover, analysis of previously published loss-of-function missense FUT1 variants, specifically p.Met228Ile, p.Trp232Arg, p.Ser262Lys, and p.Asn263His, revealed similar charge shifts near the donor or acceptor glycan binding sites within the enzyme's catalytic center, suggesting a common loss-of-function mechanism.
conclusionThis study identified a novel FUT1 variant associated with the para-Bombay phenotype and elucidated its structural impact on α2FucT1 function using an AlphaFold2-based structural model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.